Glypican-3 Rabbit Monoclonal Antibody (PE)

<strong>Glypican-3 Rabbit Monoclonal Antibody (PE) </strong>_x000D_ <strong>Catalog number:</strong> B2017727_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 25 Tests_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> GPC3, MXR7, OCI-5_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kim H, Ho M. Isolation of Antibodies to Heparan Sulfate on Glypicans by Phage Display Curr Protoc Protein Sci. 2018 Nov;94(1):e66._x000D_ 2: Huang M, Ma Y, Gao X, Li X, Ding Q, Liu C, Liu X, Zhang H, Yang N. Combining Fluorescent Cell Sorting and Single B Cell Amplification to Screen the Monoclonal Antibody Gene against Human Glypican-1 in Pancreatic Cancer J Oncol. 2021 Sep 3;2021:5646589._x000D_ 3: Zhang Y, Qiu D, Li R, Liu Y, Shi S, Wang Y. Preparation of a monoclonal antibody against the carcinoembryonic antigen, glypican‑3 Mol Med Rep. 2019 May;19(5):3889-3895._x000D_ 4: Fayn S, King AP, Gutsche NT, Duan Z, Buffington J, Olkowski CP, Fu Y, Hong J, Sail D, Baidoo KE, Swenson RE, Cheloha RW, Ho M, Choyke PL, Escorcia FE. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver Cancer by Immuno-PET J Nucl Med. 2023 Jul;64(7):1017-1023._x000D_ 5: Ma RJ, Wang SH, Qin SN, Wang XB, Li GF, Li M, Xu WW. Preparation and characterization of monoclonal antibody against glypican-3 Hybridoma (Larchmt). 2012 Dec;31(6):455-61._x000D_ 6: Fleming BD, Ho M. Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer Toxins (Basel). 2016 Sep 22;8(10):274._x000D_ 7: Vongchan P, Linhardt RJ. Characterization of a new monoclonal anti-glypican-3 antibody specific to the hepatocellular carcinoma cell line, HepG2 World J Hepatol. 2017 Mar 8;9(7):368-384._x000D_ 8: Filmus J, Capurro M. Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma FEBS J. 2013 May;280(10):2471-6._x000D_ 9: Ho M. Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin BioDrugs. 2011 Oct 1;25(5):275-84._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33374953">10: Bell MM, Gutsche NT, King AP, Baidoo KE, Kelada OJ, Choyke PL, Escorcia FE. Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma Molecules. 2020 Dec 22;26(1):4. </a>_x000D_ _x000D_ <strong>Products Related to Glypican-3 Rabbit Monoclonal Antibody (PE) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>